Long-term high-dose resveratrol supplementation reduces bone mass and strength in rats

2016 ◽  
Author(s):  
Ornstrup Marie Juul ◽  
Annemarie Bruel ◽  
Thomsen Jesper Skovhus ◽  
Torben Harslof ◽  
Langdahl Bente Lomholt ◽  
...  
Keyword(s):  
Bone Mass ◽  
High Dose

Long-Term High-Dose Resveratrol Supplementation Reduces Bone Mass and Fracture Strength in Rats

2017 ◽  
Vol 102 (3) ◽  
pp. 337-347
Author(s):  
Marie Juul Ornstrup ◽  
Annemarie Brüel ◽  
Jesper Skovhus Thomsen ◽  
Torben Harsløf ◽  
Bente Lomholt Langdahl ◽  
...  
Keyword(s):  
Bone Mass ◽  
Fracture Strength ◽  
High Dose

High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse

Bone ◽  
2005 ◽  
Vol 37 (3) ◽  
pp. 287-295 ◽  
Author(s):  
Chao Yang Li ◽  
Robert J. Majeska ◽  
Damien M. Laudier ◽  
Richard Mann ◽  
Mitchell B. Schaffler
Keyword(s):  
Bone Mass ◽  
Cancellous Bone ◽  
High Dose

Long-term high-dose resveratrol supplementation reduces bone mass and strength in rats

2016 ◽  
Author(s):  
Ornstrup Marie Juul ◽  
Annemarie Bruel ◽  
Thomsen Jesper Skovhus ◽  
Torben Harslof ◽  
Langdahl Bente Lomholt ◽  
...  
Keyword(s):  
Bone Mass ◽  
High Dose

[18F]Fluoride PET Indicates Reduced Bone Formation in Severe Glucocorticoid-induced Osteoporosis

1998 ◽  
Vol 37 (02) ◽  
pp. 76-79 ◽  
Author(s):  
T. D. Kirchhoff ◽  
W. Burchert ◽  
J. v. d. Hoff ◽  
H. Zeidler ◽  
H. Hundeshagen ◽  
...  
Keyword(s):  
Bone Formation ◽  
Multiple Organ ◽  
High Dose ◽  
Multiple Fractures ◽  
Glucocorticoid Treatment ◽  
Organ Manifestations ◽  
Diagnostic Benefit ◽  
Sharp Syndrome ◽  
18F Fluoride

SummaryA 61-year-old female patient presenting with mixed connective tissue disease (Sharp syndrome), underwent a long-term high dose glucocorticoid treatment because of multiple organ manifestations. Under steroid therapy she developed severe osteoporosis resulting in multiple fractures. A dynamic [18F]fluoride PET study in this patient revealed reduced fluoride influx in non-fractured vertebrae. This finding corresponds to pathogenetic concepts which propose an inhibition of bone formation as major cause of glucocorticoid-induced osteoporosis. In the light of the presented case it seems to be promising to evaluate the diagnostic benefit of [18F]fluoride PET in osteoporosis.

High-dose glucocorticoid therapy impairs long-term memory, but not executive function

2005 ◽  
Vol 113 (08) ◽  
Author(s):  
R Brunner ◽  
D Schaefer ◽  
K Hess ◽  
P Parzer ◽  
F Resch ◽  
...  
Keyword(s):  
Executive Function ◽  
Glucocorticoid Therapy ◽  
Long Term Memory ◽  
High Dose ◽  
Term Memory

Effects of long-term sedentary behaviour on the cortical bone mass and distribution during growth: The HAPPY bone study

2017 ◽  
Author(s):  
Rachel L Duckham ◽  
Timo Rantalainen ◽  
Christine Rodda ◽  
Anna Timperio ◽  
Nicola Hawley ◽  
...  
Keyword(s):  
Bone Mass ◽  
Cortical Bone ◽  
Sedentary Behaviour ◽  
Cortical Bone Mass
Sign in / Sign up

Export Citation Format

Share Document